573 related articles for article (PubMed ID: 16510571)
21. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
22. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors.
Alvarez JV; Febbo PG; Ramaswamy S; Loda M; Richardson A; Frank DA
Cancer Res; 2005 Jun; 65(12):5054-62. PubMed ID: 15958548
[TBL] [Abstract][Full Text] [Related]
23. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
Huang M; Page C; Reynolds RK; Lin J
Gynecol Oncol; 2000 Oct; 79(1):67-73. PubMed ID: 11006034
[TBL] [Abstract][Full Text] [Related]
24. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
25. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
[TBL] [Abstract][Full Text] [Related]
26. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway.
Tashiro E; Maruki H; Minato Y; Doki Y; Weinstein IB; Imoto M
Cancer Res; 2003 Jan; 63(2):424-31. PubMed ID: 12543798
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of anchorage-independent cell growth, adhesion, and cyclin D1 gene expression by a dominant negative mutant of a tyrosine phosphatase.
Mitra SK; Swarup G
Exp Cell Res; 2001 Oct; 270(1):32-44. PubMed ID: 11597125
[TBL] [Abstract][Full Text] [Related]
29. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
Ma XT; Wang S; Ye YJ; Du RY; Cui ZR
Ai Zheng; 2003 Nov; 22(11):1135-9. PubMed ID: 14613639
[TBL] [Abstract][Full Text] [Related]
30. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
31. A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.
Guerra E; Trerotola M; Dell' Arciprete R; Bonasera V; Palombo B; El-Sewedy T; Ciccimarra T; Crescenzi C; Lorenzini F; Rossi C; Vacca G; Lattanzio R; Piantelli M; Alberti S
Cancer Res; 2008 Oct; 68(19):8113-21. PubMed ID: 18829570
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells.
Anagnostopoulou A; Vultur A; Arulanandam R; Cao J; Turkson J; Jove R; Kim JS; Glenn M; Hamilton AD; Raptis L
Cancer Lett; 2006 Oct; 242(1):120-32. PubMed ID: 16377083
[TBL] [Abstract][Full Text] [Related]
33. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
[TBL] [Abstract][Full Text] [Related]
34. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
[TBL] [Abstract][Full Text] [Related]
35. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells.
Wojcik EJ; Sharifpoor S; Miller NA; Wright TG; Watering R; Tremblay EA; Swan K; Mueller CR; Elliott BE
Oncogene; 2006 May; 25(19):2773-84. PubMed ID: 16407846
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
37. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
Yu CY; Wang L; Khaletskiy A; Farrar WL; Larner A; Colburn NH; Li JJ
Oncogene; 2002 Jun; 21(25):3949-60. PubMed ID: 12037677
[TBL] [Abstract][Full Text] [Related]
38. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
39. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
